Insight

Tony Cillo: Excited to share our paper on anti-PD1+anti-LAG3 therapy in melanoma

Photo take from Tony Cillo/X

Aug 9, 2024, 12:57

Tony Cillo: Excited to share our paper on anti-PD1+anti-LAG3 therapy in melanoma

Tony Cillo, Assistant professor in the Department of Immunology at the University of Pittsburgh.

“Excited to share our paper out today in Cell with Tullia Bruno from Vignali Lab! Part of a trio of papers, we show in Melanoma, anti-PD1+anti-LAG3 therapy modifies CD8 differentiation to promote enhanced effector function.

‘Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8⁺ T cells to promote antitumor immunity‘

Authors: Anthony R. Cillo, Carly Cardello, Feng Shan, Lilit Karapetyan, Sheryl Kunning, Cindy Sander, Elizabeth Rush, Arivarasan Karunamurthy, Ryan C. Massa, Anjali Rohatgi, Creg J. Workman, John M. Kirkwood, Tullia C. Bruno, Dario A.A. Vignali.”

Source: Tony Cillo/X

Anjali Rohatgi Anthony R. Cillo Arivarasan Karunamurthy cancer Carly Cardello Cindy Sander Creg J. Workman Dario A.A. Vignali Elizabeth Rush Feng Shan John M. Kirkwood Lilit Karapetyan Melanoma OncoDaily Oncology Ryan C. Massa Sheryl Kunning Tony Cillo Tullia Bruno Tullia C. Bruno Vignali Lab

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage